Sponsor: Merck
Sponsor Study ID: MK2870-015
Study Title: A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physicians Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma
CTO #: 104009
NCT Number: NCT06356311
Phase: III
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Esophagus
Study Objectives: